Plasticell launches second generation CombiCultTM screening platform Company wins Frost & Sullivan 2010 European Technology Innovation Award

London, UK, 12 October 2010 Plasticell, the biotechnology company specialising in high throughput screening for stem cell differentiation, announces the launch of its second generation CombicultTM 10,000-Plex Screen capable of rapidly screening up to ten thousand cell culture media combinations. At the same time, the company is pleased to announce that it has won the Frost & Sullivan 2010 European [...]

2017-01-08T18:13:43+00:00October 12th, 2010|News Articles|

Combinatorial Cell Culture™ patent granted in Europe and other regions

London, UK, 2 August 2009. Plasticell, the biotechnology company developing regenerative drugs using high throughput stem cell technologies, has announced that patents protecting its proprietary cell culture technology, Combinatorial Cell Culture™ (CombiCult™), have been granted by the European Patent Office, Australian Patent Office and Intellectual Property Office of Singapore. The granted patents cover high throughput and combinatorial methods of carrying out cell culture and exemplify [...]

2017-01-08T18:11:40+00:00August 2nd, 2009|News Articles|

Plasticell closes first institutional financing round

London, UK, 23 November 2007. Plasticell, the biotechnology company developing regenerative drugs using high throughput stem cell technologies, has announced the closing of a £690,000 financing round involving an institutional investor for the first time. The fundraising was comprised of a rights issue in which £440,000 was raised from a number of founding shareholders, followed by investment of £250,000 from [...]

2017-01-08T17:54:25+00:00November 23rd, 2007|News Articles|